Efficacy and Tolerability of Indacaterol 75 μg Once Daily in Patients Aged ≥40 Years With Chronic Obstructive Pulmonary Disease: Results From 2 Double-Blind, Placebo-Controlled 12-Week Studies

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.11.009 ◽

2011 ◽

Vol 33 (12) ◽

pp. 1974-1984 ◽

Author(s):

Edward M. Kerwin ◽

Mark H. Gotfried ◽

David Lawrence ◽

Cheryl Lassen ◽

Benjamin Kramer

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718489447.793532747 ◽

2017 ◽

Author(s):

Ravi Kalhan ◽

Sharon R Rosenberg

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

Respiratory Research ◽

10.1186/1465-9921-15-78 ◽

2014 ◽

Vol 15 (1) ◽

Author(s):

James F Donohue ◽

Dennis Niewoehner ◽

Jean Brooks ◽

Dianne O’Dell ◽

Alison Church

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30057-7 ◽

2016 ◽

Vol 36 (4) ◽

pp. 418-426 ◽

Author(s):

Liu Miao ◽

Zheng Fengjie ◽

Ni Lei ◽

Sun Yan ◽

Wu Ruohan ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Adjuvant Therapy ◽

Dietary Fiber ◽

Pulmonary Disease ◽

Sugarcane Bagasse ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Supplemental dietary nitrate for chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled, crossover trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665113001705 ◽

2013 ◽

Vol 72 (OCE3) ◽

Author(s):

C. P. Kerley ◽

K. Cahill ◽

K. Bolger ◽

K. Fennell ◽

A. O'Brien ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Crossover Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Dietary Nitrate ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Download Full-text

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2017.02.008 ◽

2017 ◽

Vol 125 ◽

pp. 39-48 ◽

Author(s):

Anthony D'Urzo ◽

Stephen Rennard ◽

Edward Kerwin ◽

James F. Donohue ◽

Alejhandra Lei ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Extension Study ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

A multicenter randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of rhubarb in treating acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2016.07.002 ◽

2016 ◽

Vol 3 (2) ◽

pp. 71-80

Author(s):

Fengjie Zheng ◽

Yan Sun ◽

Xianggen Zhong ◽

Yueqi Wang ◽

Ruohan Wu ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text